Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
January 24 2025 - 12:04PM
Edgar (US Regulatory)
JPMorgan Chase Financial Company LLC
Free Writing Prospectus Filed Pursuant to
Rule 433
Registration Statement Nos. 333-270004 and
333-270004-01
Dated January 24, 2025
15m
SPX/RTY Enhanced Trigger Jump Securities
This document provides a summary of the terms of the securities.
Investors must carefully review the accompanying preliminary pricing supplement referenced below, product supplement, underlying supplement,
prospectus supplement, prospectus and prospectus addendum and the “Risk Considerations” on the following page, prior to making
an investment decision.
SUMMARY TERMS |
Issuer: |
JPMorgan Chase Financial Company LLC (“JPMorgan Financial”) |
Guarantor: |
JPMorgan Chase & Co. |
Underlying indices: |
S&P 500® Index (Bloomberg ticker: SPX Index) (the “SPX Index”) and Russell 2000® Index (Bloomberg ticker: RTY Index) (the “RTY Index”) (each an “underlying index”) |
Payment at maturity: |
If the final index value of each underlying index is greater than
or equal to its trigger level, you will receive at maturity a cash payment per $1,000 stated principal amount security equal to:
$1,000 + upside payment
If the final index value of either underlying index is less than
its trigger level, you will receive at maturity a cash payment per $1,000 stated principal amount security equal to:
$1,000 × index performance factor of the worse performing underlying
index
This amount will be less than the stated principal amount of $1,000
and will represent a loss of more than 20%, and possibly all, of your principal amount. |
Upside payment: |
At least $103.70 per $1,000 stated principal amount security (at least 10.37% of the stated principal amount) |
Trigger level: |
With respect to each underlying index, 80% of its initial index value |
Index performance factor: |
With respect to each underlying index, final index value / initial index value |
Initial index value: |
With respect to each underlying index, its closing level on the pricing date |
Final index value: |
With respect to each underlying index, its closing level on the valuation date |
Worse performing underlying index: |
The underlying index with the lower index performance factor |
Stated principal amount: |
$1,000 per security |
Issue price: |
$1,000 per security |
Pricing date: |
Expected to be January 31, 2025 |
Original issue date (settlement date): |
3 business days after the pricing date |
Valuation date†: |
April 30, 2026 |
Maturity date†: |
May 5, 2026 |
CUSIP / ISIN: |
48136BMR9 / US48136BMR95 |
Preliminary pricing supplement: |
http://www.sec.gov/Archives/edgar/data/19617/
000121390025006317/ea0228652-01_424b2.htm |
†Subject to postponement
The estimated value of the securities on the pricing date will be provided
in the pricing supplement and will not be less than $950.00 per $1,000 stated principal amount security. For information about the estimated
value of the securities, which likely will be lower than the price you paid for the securities, please see the hyperlink above.
Any payment on the securities is subject to the credit risk of JPMorgan
Financial, as issuer of the securities, and the credit risk of JPMorgan Chase & Co., as guarantor of the securities.
Enhanced Trigger Jump Securities Payoff Diagram* |
|
*The actual upside payment will be provided in the pricing supplement
and will not be less than $103.70 per security.
Change in Worse Performing Underlying
Index |
Return on the Securities* |
80.00% |
10.37% |
70.00% |
10.37% |
60.00% |
10.37% |
50.00% |
10.37% |
40.00% |
10.37% |
30.00% |
10.37% |
20.00% |
10.37% |
10.37% |
10.37% |
10.00% |
10.37% |
5.00% |
10.37% |
1.00% |
10.37% |
0.00% |
10.37% |
-10.00% |
10.37% |
-20.00% |
10.37% |
-20.01% |
-20.01% |
-30.00% |
-30.00% |
-40.00% |
-40.00% |
-50.00% |
-50.00% |
-60.00% |
-60.00% |
-80.00% |
-80.00% |
-100.00% |
-100.00% |
*Assumes an upside payment of 10.37% of the stated principal amount |
JPMorgan Chase Financial Company LLC
15m
SPX/RTY Enhanced Trigger Jump Securities
Underlying Indices
For more information about the underlying
indices, including historical performance information, see the accompanying preliminary pricing supplement.
Risk Considerations
The risks identified below are not exhaustive. Please see “Risk
Factors” in the accompanying prospectus supplement, product supplement and preliminary pricing supplement and Annex A to the accompanying
prospectus addendum for additional information.
Risks Relating to the Securities
Generally
| § | The securities do not pay interest or guarantee the return of any principal and your investment in the
securities may result in a loss. |
| § | Appreciation potential is fixed and limited. |
| § | Your ability to receive the upside payment may terminate on the valuation date. |
| § | You are exposed to the price risk of each underlying index. |
| § | To receive the upside payment, each underlying index must close at or above its trigger level on the
valuation date. |
| § | Because the securities are linked to the performance of the worse performing underlying index, you are
exposed to greater risks of sustaining a loss on your investment than if the securities were linked to just one underlying index. |
| § | The securities are subject to the credit risks of JPMorgan Financial and JPMorgan Chase & Co.,
and any actual or anticipated changes to our or JPMorgan Chase & Co.’s credit ratings or credit spreads may adversely
affect the market value of the securities. |
| § | As a finance subsidiary, JPMorgan Financial has no independent operations and has limited assets. |
| § | The benefit provided by the trigger level may terminate on the valuation date. |
| § | Secondary trading may be limited. |
| § | The final terms and estimated valuation of the securities will be provided in the pricing supplement. |
| § | The tax consequences of an investment in the securities are uncertain. |
Risks Relating to Conflicts
of Interest
| § | Economic interests of the issuer, the guarantor, the calculation agent, the agent of the offering of
the securities and other affiliates of the issuer may be different from those of investors. |
| § | Hedging and trading activities by the issuer and its affiliates could potentially affect the value of
the securities. |
Risks Relating to the Estimated
Value and Secondary Market Prices of the Securities
| § | The estimated value of the securities will be lower than the original issue price (price to public) of
the securities. |
| § | The estimated value of the securities does not represent future values of the securities and may differ
from others’ estimates. |
| § | The estimated value of the securities
is derived by reference to an internal funding rate. |
| § | The value of the securities
as published by J.P. Morgan Securities LLC (and which may
be reflected on customer account statements) may be higher than the then-current estimated value of the securities for
a limited time period. |
| § | Secondary market prices of the securities will likely be lower than the original issue price of the securities.
|
| § | Secondary market prices of the securities
will be impacted by many economic and market factors. |
Risks Relating to the Underlying
Indices
| § | JPMorgan Chase & Co. is
currently one of the companies that make up the SPX Index. |
| § | An investment in the securities is subject
to risks associated with small capitalization stocks with respect to the RTY Index. |
| § | Investing in the securities is not equivalent
to investing in either underlying index. |
| § | Adjustments to either underlying index
could adversely affect the value of the securities. |
| § | Governmental legislative and regulatory
actions, including sanctions, could adversely affect your investment in the securities. |
Tax Considerations
You should review carefully the discussion in the accompanying preliminary
pricing supplement under “Additional Information about the Securities — Tax considerations” concerning the U.S. federal
income tax consequences of an investment in the securities, and you should consult your tax adviser.
SEC Legend: JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co.
have filed a registration statement (including a prospectus) with the SEC for any offerings to which these materials relate. Before you
invest, you should read the prospectus in that registration statement and the other documents relating to this offering that JPMorgan
Chase Financial Company LLC and JPMorgan Chase & Co. has filed with the SEC for more complete information about JPMorgan
Chase Financial Company LLC and JPMorgan Chase & Co. and this offering. You may get these documents without cost by visiting
EDGAR on the SEC web site at www.sec.gov. Alternatively, JPMorgan Chase Financial Company LLC and JPMorgan Chase & Co.,
any agent or any dealer participating in the this offering will arrange to send you the prospectus and each prospectus supplement as
well as any product supplement, underlying supplement and preliminary pricing supplement if you so request by calling toll-free 1-866-535-9248.
Alerian Mlp Index ETNs d... (AMEX:AMJB)
Historical Stock Chart
From Dec 2024 to Jan 2025
Alerian Mlp Index ETNs d... (AMEX:AMJB)
Historical Stock Chart
From Jan 2024 to Jan 2025